"PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation." Gastroenterology
On 23-24 July 2026, the US Food and Drug Administrations Pharmacy Compounding Advisory Committee recommended that six of seven peptides it assessed (BPC-157, KPV, TB-500,MOTS-c, epitalon and semax) be considered for inclusion on the section 503A Bulks List, potentially permitting their use in patient-specific compounded preparations.[2,7] The votes were close and advisory
Metabolic by-product changes: shifts in bacteria can influence microbial metabolites that affect host metabolism
If youre tired of feeling run down, inflamed, or not like yourselfits time to take a different approach
The cognitive tricks If theyre expensive, we have no idea if they work, and theres a possibility theyre unsafe, what makes peptides so appealing